EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $162,000 | -9.8% | 20,797 | -5.3% | 0.00% | – |
Q2 2023 | $179,700 | +43.8% | 21,956 | +25.1% | 0.00% | – |
Q1 2023 | $125,000 | -17.8% | 17,544 | -0.6% | 0.00% | – |
Q4 2022 | $152,000 | -12.6% | 17,644 | +23.0% | 0.00% | – |
Q3 2022 | $174,000 | -38.7% | 14,341 | +33.0% | 0.00% | -100.0% |
Q4 2021 | $284,000 | -80.3% | 10,782 | -69.2% | 0.00% | -75.0% |
Q3 2021 | $1,440,000 | -56.5% | 35,032 | -40.0% | 0.00% | -60.0% |
Q2 2021 | $3,308,000 | +130.8% | 58,362 | +71.6% | 0.01% | +100.0% |
Q1 2021 | $1,433,000 | -17.2% | 34,017 | +37.3% | 0.01% | -28.6% |
Q4 2020 | $1,731,000 | +142.4% | 24,773 | -2.2% | 0.01% | +133.3% |
Q3 2020 | $714,000 | +36.3% | 25,335 | +44.2% | 0.00% | 0.0% |
Q2 2020 | $524,000 | +143.7% | 17,565 | +59.2% | 0.00% | +200.0% |
Q1 2020 | $215,000 | -53.5% | 11,035 | -40.7% | 0.00% | -66.7% |
Q2 2019 | $462,000 | +8.7% | 18,619 | +4.9% | 0.00% | 0.0% |
Q1 2019 | $425,000 | +94.1% | 17,747 | +158.1% | 0.00% | +50.0% |
Q3 2018 | $219,000 | – | 6,876 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |